Survival after pleural malignant mesothelioma: A population-based study in Italy

Tumori

Volumn 88, Issue 4, 2002, Pages 266-269

  Magnani, Corrado ^a   Viscomi, Silvia ^a   Dalmasso, Paola ^a   Ivaldi, Cristiana ^a   Mirabelli, Dario ^a   Terracini, Benedetto ^a  

^a Dipartimento di Science Biomediche E Oncologia Umana   (Italy)

Author keywords

Mesothelioma; Pleura; Survival

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER REGISTRY; CANCER SURVIVAL; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ITALY; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PERITONEUM MESOTHELIOMA; PLEURA MESOTHELIOMA; POPULATION RESEARCH; SURVIVAL TIME;

EID: 0036658682     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160208800403     Document Type: Article

References (31)

1. McDonald JC, McDonald AD: The epidemiology of mesothelioma in historical context. Eur Respir J, 9: 1932-1942, 1996.
2. Sterman DH, Kaiser LR, Albelda SM: Advances in the treatment of malignant pleural mesothelioma. Chest, 116: 504-520, 1999.
3. Curran D, Sahmoud T, Therasse P, Van Meerbeeck J, Postmus PE, Giaccone G: Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol, 16: 145-152, 1998.
4. Chahinian AP, Pajak TF, Holland JF, Norton L, Ambinder RM, Mandel EM: Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Intern Med, 96: 746-755, 1982.
5. Adams VI, Unni KK, Muhm JR, Jett JR, Ilstrup DM, Bernatz PE: Diffuse malignant mesothelioma of pleura. Diagnosis and survival in 92 cases. Cancer, 58: 1540-1551, 1986.
6. Antman K, Shemin R, Ryan L, Klegar K, Osteen R, Herman T, Lederman G, Corson J: Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. J Clin Oncol, 6: 147-153, 1988.
7. Alberts AS, Falkson G, Goedhals L, Vorobiof DA, Van der Merwe CA: Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers. J Clin Oncol, 6: 527-535, 1988.
8. Spirtas R, Connelly RR, Tucker MA: Survival patterns for malignant mesothelioma: the SEER experience. Int J Cancer, 41: 525-530, 1988.
9. Chailleux E, Dabouis G, Pioche D, De Lajartre M, De Lajartre AY, Rembeaux A, Germaud P: Prognostic factors in diffuse malignant pleural mesothelioma. A study of 167 patients. Chest, 93: 159-162, 1988.
10. Ruffie P, Feld R, Minkin S, Cormier Y, Boutan-Laroze A, Ginsberg R, Ayoub J, Shepherd FA, Evans WK, Figueredo A, Pater JL, Pringle JF, Kreisman H: Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol, 7: 1157-1168, 1989.
11. Tammilehto L, Maasilta P, Kostiainen S, Appelqvist P, Holsti LR, Mattson K: Diagnosis and prognostic factors in malignant pleural mesothelioma: a retrospective analysis of sixty-five patients. Respiration, 59: 129-135, 1992.
12. De Pangher Manzini V, Brollo A, Franceschi S, De Matthaeis M, Talamini R, Bianchi C: Prognostic factors of malignant mesothelioma of the pleura. Cancer, 72: 410-417, 1993.
13. Boutin C, Rey F, Gouvernet J, Viallat JR, Astoul P, Ledoray V: Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging. Cancer, 72: 394-404, 1993.
14. Herndon JE, Green MR, Chahinian AP, Corson JM, Suzuki Y, Vogelzang NJ: Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest, 113: 723-731, 1998.
15. Rusch VW, Venkatraman ES: Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg, 68: 1799-1804, 1999.
16. Edwards JG, Abrams KR, Leverment JN, Spyt TJ, Waller DA, O'Byrne KJ: Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax, 55: 731-735, 2000.
17. Peto J, Hodgson JT, Matthews FE, Jones JR: Continuing increase in mesothelioma mortality in Britain. Lancet, 345: 535-539, 1995.
18. Ilg AG, Bignon J, Valleron AJ: Estimation of the past and future burden of mortality from mesothelioma in France. Occup Environ Med, 55: 760-765, 1998.
19. Peto J, Decarli A, La Vecchia C, Levi F, Negri E: The European mesothelioma epidemic. Br J Cancer, 79: 666-672, 1999.
20. Merler E, Lagazio C, Biggeri A: Trends in mortality from primary pleural tumor and incidence of pleural mesothelioma in Italy: a particularly serious situation. Epidemiol Prev, 23: 316-326, 1999.
21. Janssen-Heijnen ML, Damhuis RA, Klinkhamer PJ, Schipper RM, Coebergh JW: Increased but low incidence and poor survival of malignant mesothelioma in the southeastern part of The Netherlands since 1970: a population-based study. Eur J Cancer Prev, 8: 311-314, 1999.
22. Berrino F, Gatta G, Chessa E, Valente F, Capocaccia R: The EUROCARE II study. Eur J Cancer, 34: 2139-2153, 1998.
23. Ivaldi C, Dalmasso P, Nesti M, Magnani C: Malignant Mesothelioma Registry from Piedmont. Incidence in 1990-1995. Epidemiol Prev, 23: 308-315, 1999.
24. Andrion A, Magnani C, Betta PG, Donna A, Mollo F, Scelsi M, Bernardi P, Botta M, Terracini B: Malignant mesothelioma of the pleura: interobserver variability. J Clin Pathol, 48: 856-860, 1995.
25. Magnani C, Agudo A, Gonzalez CA, Andrion A, Calleja A, Chellini E, Dalmasso P, Escolar P, Hernandez S, Ivaldi C, Mirabelli D, Ramirez J, Turuguet D, Usel M, Terracini B: Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos. Br J Cancer, 83: 104-111, 2000.
26. Pastore G, Mosso ML, Carnevale F, Cordero di Montezemolo L, Forni M, Madon E, Ricardi U, Terracini B Magnani C: Survival trends of childhood cancer diagnosed during 1970-1994 in Piedmont, Italy: a report from the Childhood Cancer Registry. Med Pediatr Oncol, 36: 481-488, 2001.
27. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc, 53: 457-481, 1958.
28. Marubini E, Valsecchi: Analysing survival data from clinical trials and observational studies, p 430, Wiley, New York, 1995.
29. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II: analysis and examples. Br J Cancer, 5: 1-39, 1977.
30. Cox, D: Regression models and life-tables. J R Soc Stat, 34: 187-220, 1972.
31. Betta PG, Andrion A, Donna A, Mollo F, Scelsi M; Zai G, Terrracini B, Magnani C: Malignant mesothelioma of the pleura. The reproducibility of the immunohistological diagnosis. Pathol Res Pract, 193: 759-765, 1997.